Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Free Cash Flow (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) recorded Free Cash Flow of $80.39 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 66.3% from $238.42 million a year earlier but up 204.6% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Free Cash Flow (2009 - 2026) Analysis & Trends

On a TTM basis, Dr Reddys Laboratories' Free Cash Flow came in at $13.96 million as of Sep 30, 2026, down 98.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $378.74 million, up 69.8% from FY2025.

  • Annual Free Cash Flow has a five-year compound annual growth rate of 1.3% (FY2021 to FY2026).
  • Across earlier fiscal years, Free Cash Flow came in at $223 million in FY2025 (-35.9%), $348 million in FY2024 (-39.8%), $578 million in FY2023 (+226.6%) and $177 million in FY2022 (-50.1%).
  • Quarterly Free Cash Flow has ranged from -$249.76 million in fiscal Q4 2026 to $318.93 million in fiscal Q3 2023 over the past five years.
  • On a year-over-year basis, Free Cash Flow rose in two of the last four quarters, with an average decline of 20.8%.
  • Peak year-over-year performance for Free Cash Flow in the last five years was growth of 196.5% in fiscal Q3 2022, against a decline of 89.5% in fiscal Q1 2027 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $26.4 million (Q1 2027), -$249.76 million (Q4 2026) and $156.93 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 8.22 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 6.36 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 7.31 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 5.52 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 7.96 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 3.65 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 4.80 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 4.80 Bn
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn 80.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 80.39 Mn
Jun 30, 2026 26.40 Mn
Mar 31, 2026 -249.76 Mn
Dec 31, 2025 156.93 Mn
Sep 30, 2025 238.42 Mn
Jun 30, 2025 251.10 Mn
Sep 30, 2024 201.20 Mn
Jun 30, 2024 163.10 Mn
Mar 31, 2024 -193.17 Mn
Dec 31, 2023 102.96 Mn
Sep 30, 2023 261.42 Mn
Jun 30, 2023 181.22 Mn
Mar 31, 2023 -4.68 Mn
Dec 31, 2022 318.93 Mn
Sep 30, 2022 147.90 Mn
Jun 30, 2022 129.17 Mn
Mar 31, 2022 -218.90 Mn
Dec 31, 2021 286.54 Mn
Sep 30, 2021 117.24 Mn
Jun 30, 2021 -3.36 Mn
API Access

Dr Reddys Laboratories Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=RDY&period=max&api_key=YOUR_API_KEY